pharma · sickle cell anaemia · Chronic Obstructive Pulmonary Disease
Pierre Fabre Medical
Pierre Fabre Australia Pty Ltd
Pierre Fabre Medical clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- North Sydney, AU
- Founded
- 2002
- Employees
- 5
- Programs
- 3
- Drugs
- 18
- Patents
- 0
Pierre Fabre Medical projects
3 ClinicalTrials.gov programs sponsored by Pierre Fabre Medical.
Pierre Fabre Medical has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
LIDOCAINE HYDROCHLORIDE, MORPHINE HYDROCHLORIDE
Pierre Fabre Australia Pty Ltd
sickle cell anaemia
1 trial -
The impact of extra-fine inhalation corticost...
Pierre Fabre Australia Pty Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
The papillon study
Pierre Fabre Australia Pty Ltd
giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral
1 trial
Frequently asked questions
How many clinical projects does Pierre Fabre Medical have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.